Skip to main content
. 2019 Jun 21;2(6):e195892. doi: 10.1001/jamanetworkopen.2019.5892

Figure 2. Cumulative Incidence Rates of the Primary Outcome Measure in the Propensity Score–Matched Cohort.

Figure 2.

Log-rank P = .003 (A), P = .85 (B), and P < .001 (C). MRA indicates mineralocorticoid receptor antagonist.